Featured Videos

The MD Learning Channel is a free, one-stop shop for clinical education resources.

Autonomic Function Testing Kazamel


Release Date: September 27, 2016
Expiration Date: September 27, 2019


Target Audience: Neurologists and primary care physicians
Disclosure: Dr. Kazamel has no financial relationships related to the content of this activity to disclose. There is no commercial support for this activity.


Take Test Now >>

Autonomic Function Testing

Learning Objective / Overview: Autonomic function testing is the category of electrodiagnostic and clinical neurophysiology testing that is employed in the evaluation of sympathetic and parasympathetic neural pathways. Examining the integrity of these pathways is necessary in objectively evaluating many neurologic and cardiac conditions like orthostatic hypotension, recurrent syncopal episodes, and postural orthostatic tachycardia syndrome (POTS). Neurologists often time need to evaluate the functions of the thinly myelinated and non-myelinated small nerve fibers. These population of fibers cannot be assessed by routine nerve conduction studies or electromyography. The presence of autonomic dysfunction is a key criterion for the diagnosis of a life threatening condition like multiple system atrophy that distinguishes it from other more benign parkinsonian syndromes.

Accreditation statement:The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Utilizing SEEG, the ROSA robot, & NeuroPace in Epilepsy Treatment

Kristen Riley, MD, highlights some of the new technology being used at UAB Medicine for the surgical management of epilepsy patients, such as Stereoelectroencephalography (SEEG), the ROSA Robot, responsive neurostimulation with NeuroPace, and why this makes the UAB Epilepsy Center so unique.

Emergency Medical Stroke Assessment (EMSA)

Earlier identification of strokes will lead to earlier treatment and better outcomes. Are you properly equipped to identify a stroke? EMSA can help.

Click here for the lecture slides >

Deep Brain stimulation parkinson's disease
Patient Outcomes: An Overview of Deep Brain Stimulation for Parkinson's Disease
An overview of the use of deep brain stimulation (DBS) in the treatment of movement disorders.
Ischemic stroke IV tPA
Ischemic Stroke Update
Ischemic stroke is both a preventable disease and a treatable disease. IV tPA is the only FDA approved treatment for acute ischemic stroke, and expedited delivery of this drug in the appropriate setting should not be delayed because every second counts
Jerzy Szaflarski UAB Epilepsy Center
Epilepsy Care at UAB Medicine
Jerzy Szaflarski, MD, PhD, discusses the treatment & research within the UAB Epilepsy Center, and highlights what makes this a Level 4 Epilepsy Center. Dr. Szaflarski reviews the prevalence of epilepsy in Alabama, as well as the treatment methodologies and care plans available.
Lawrence Ver Hoef Diagnosis Epilepsy
Diagnosing & Evaluating the Modern Epilepsy Patient
Lawrence Ver Hoef, MD, discusses the diagnosis and evaluation process for epilepsy patients with the UAB Epilepsy Center. He highlights the referral process for epilepsy patients, and working with community neurologists throughout the state.
Multiple Sclerosis Therapeutics John Rinker
Update on MS Therapeutics
Dr. John R. Rinker II gives an update on Multiple Sclerosis Therapeutics.
Mark Harrigan Intracerebral Hemorrhage
New Developments in the Management of Intracerebral Hemorrhage
Dr. Mark R. Harrigan discusses New Developments in the Management of Intracerebral Hemorrhage
Harrison Walker Deep Brain Stimulation DBS
Deep Brain Stimulation for Movement Disorders
Dr. Harrison Walker presents on the use of Deep Brain Stimulation (DBS) in treating movement disorders.
Pituitary Skull Base Surgery Kristen Riley
Update on Pituitary and Skull Base Surgery
Dr. Kristen O. Riley discusses updates on Pituitary and Skull Base Surgery.
Erik Roberson Alzheimer’s
Updates in Diagnosis & Therapeutics in Alzheimer’s
Erik Roberson, MD, PhD, FANA, reviewed the most recent updates in the diagnosis and therapeutics in Alzheimer’s disease. He highlighted the natural history of the disease, diagnostic criteria and imaging, as well as the latest in treatment options.
Lawrence Ver Hoef epilepsy drugs
Diagnosis & Classification of Seizures
Lawrence Ver Hoef, MD discusses approaches for the diagnosis and classification of seizures, shares insight for cutting edge treatment and the latest in epilepsy drugs development.
Kristen Riley temporal lobectomy epilepsy
Surgical Management of Epilepsy-Temporal Lobectomy & Beyond
This presentation will discuss the range of surgical options for epilepsy patients, from temporal lobectomy, to staged surgeries with invasive monitoring to stimulation procedures.